Phreesia, Inc. ver: 2

Q1 2022 Earnings Conference Call


spk_2: Sure operator. Today's call is scheduled to begin momentarily again. Your line will be a music hold until the conference begins. Thank you for your patients. Good morning ladies and gentlemen and welcome to fresh fiscal first quarter 2022 earnings report at this time. All participants arena. Listen only mode. We will provide instructions for the question and answer session to follow first. I would like to introduce biology Gandhi, senior vice president, investor relations for freesia. Mr Gandhi. You may begin.
spk_0: Thank you operator. Good morning and welcome to fresh eggs earnings conference call for the fiscal first quarter of 2022, which ended on April 30, Joining me on today's call, our Freesias Chief executive officer and co founder. I'm in Big and Chief financial officer Randy Rasmussen. Complete disclosure of our results can be found in our earnings press release issued yesterday evening, As well as in our related form eight K submission to the sec R A K filing includes the first installment of our quarterly stakeholder letter, which we are implementing to provide additional information about Freesia during the quarter, in advance of our earnings call to provide greater efficiency to our earnings reporting process for the benefit of our stakeholders. All these documents are available on the investor relations section of our website at ir freesia dot com. As a reminder, today's call is being recorded and replay will be available following the conclusion of the call. During today's call. We will make forward looking statements within the meaning of Section 27 A of the Securities Act In Section 21 Year and the Securities Exchange Act. Although we believe that the expectations reflected in these forward looking statements are reasonable. These statements relate to future events or our future operational or financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements. Express or implied by these forward looking statement. Furthermore, actual results may differ materially from those described in the forward looking statements and will be affected by a variety of risk and factors that are beyond our control, including without limitation, statements about our future financial performance, including our revenue, cash flows, cost of revenue and operating expenses Are anticipated growth. Our predictions about our industry, the impact of the COVID-19 pandemic on our business and our ability to attract, retain and cross sell to healthcare provider clients, statements are also subject to other risks and uncertainties, including those more fully described in our filings with the sec, including in our quarterly report on form 10-Q. That will be filed with the sec later today. The forward looking statements made on this call speak only as of the date on which the statements are made. We undertake no obligation to update and expressly disclaims any obligation to update any forward looking statements to reflect events poor circumstances after the day that this call, or to reflect new information or the occurrence of unanticipated events, except as required by law, we will also refer to certain financial measures, not in accordance with generally accepted accounting principles in order to provide additional information to investors. Non gap measures should be considered in addition to and not as a substitute for or in isolation from our gap results. A reconciliation of gap to non gap results may be found on her earnings press release and supplemental materials which were furnished with our Form A K. Filed after the markets closed on june 3rd with the sec. And they also be

This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only. Earnings Call, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.